InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Hecht Beth, Dirigeant. Insider active across 3 companies, notably Xeris Biopharma Holdings, Inc.. In total, 8 filings have been recorded. The latest transaction was filed on 23 June 2022 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations8 total
036,798 shares0
Ordinary Shares
SEC:0001209191-22-039311:0·
07,642 shares0
Ordinary Shares
SEC:0001209191-22-020618:0·
0225,000 shares0
Common Stock
SEC:0001867096-22-000009·
0225,000 shares0
Common Stock
SEC:0001867096-22-000009:0·
26,366 shares
Common Stock
SEC:0000899243-21-039317·
26,366 shares
Common Stock
SEC:0000899243-21-039248·
26,366 shares
Common Stock
SEC:0000899243-21-039317:0·
26,366 shares
Common Stock
SEC:0000899243-21-039248:0·
8 of 8 declarations
About Hecht Beth
Beth Hecht is an Executive at Xeris Biopharma Holdings, Inc., Xeris Pharmaceuticals Inc, and Iterum Therapeutics plc. She plays a key role in the strategic direction of these companies, bringing her expertise in product development and research. Her commitment is essential for achieving growth objectives.
